Hobbs FDR, McManus RJ, Taylor CJ, Jones NR, et al. Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial. Nat Med 2024 Sep 30. doi: 10.1038/s41591-024-03263.
PMID: 39349629